Capital World Investors holds 5.6% stake in Moderna
Capital World Investors, a division of Capital Research and Management Company and related investment management entities, reported beneficial ownership of 22,276,996 shares of Moderna, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Capital World Investors, a division of Capital Research and Management Company and related investment management entities, reported beneficial ownership of 22,276,996 shares of Moderna, Inc. common stock. This represents 5.6% of the 396,786,259 shares believed to be outstanding as of the report.
Capital World Investors has sole voting power over 22,264,639 shares and sole dispositive power over 22,276,996 shares, with no shared voting or dispositive power reported. The filing reflects passive institutional ownership rather than any stated change in control intentions.
Key Figures
Key Terms
beneficial owner financial
Sole Voting Power financial
Sole Dispositive Power financial
Schedule 13G regulatory
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Moderna (MRNA) does Capital World Investors own?
Is Capital World Investors’ Moderna (MRNA) stake reported as beneficial ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.